DeepMed Research

China National Biotec Group Company Limited

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD

Phase 4

Conditions: COVID-19
Chronic Bronchitis
COPD

Interventions: Biological: Inactivated COVID-19 vaccine

First Posted Date: 2021-11-02

Last Posted Date: 2021-11-02

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 400

Registration Number: NCT05104216

Locations: 🇨🇳
Zhejiang provincial center for disease control and prevention, Hangzhou, Zhejiang, China

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed

Phase 3

Active, not recruiting

Conditions: Diphtheria
Whooping Cough
Tetanus

Interventions: Biological: Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed
Biological: Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed) and Haemophilus influenzae type b conjugate vaccine
Biological: Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed

First Posted Date: 2021-10-25

Last Posted Date: 2023-06-18

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 2898

Registration Number: NCT05091619

Locations: 🇨🇳
Wen County Center for Disease Control and Prevention, Jiaozuo, Henan, China
🇨🇳
Neihuang County Center for Disease Control and Prevention, Anyang, Henan, China
🇨🇳
Wuyang County Center for Disease Control and Prevention, Luohe, Henan, China

and more 1 locations

Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4

Phase 4

Conditions: COVID-19 Pneumonia
Pneumonia, Pneumococcal
Influenza, Human

Interventions: Biological: COVAX+PPV23;COVAX+IIV4
Biological: COVAX only (1st and 2nd dose)
Biological: PPV23 for the 1st dose and IIV4 for the 2nd dose

First Posted Date: 2021-10-15

Last Posted Date: 2021-10-15

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 1404

Registration Number: NCT05079152

Locations: 🇨🇳
Guangdong Center for Disease Control and Prevention, Guangzhou, Guangdong, China
🇨🇳
Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China
🇨🇳
Hubei Center for Disease Control and Prevention, Wuhan, Hubei, China

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD

Phase 4

Conditions: COVID-19
Chronic Bronchitis
COPD

Interventions: Biological: Inactivated COVID-19 vaccine

First Posted Date: 2021-10-12

Last Posted Date: 2021-10-22

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 400

Registration Number: NCT05075083

Locations: 🇨🇳
Zhejiang provincial center for disease control and prevention, Hangzhou, Zhejiang, China

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected

Phase 4

Conditions: COVID-19
HIV Infections

Interventions: Biological: Inactivated COVID-19 vaccine

First Posted Date: 2021-10-12

Last Posted Date: 2021-10-22

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 400

Registration Number: NCT05075070

Locations: 🇨🇳
Zhejiang provincial center for disease control and prevention, Hangzhou, Zhejiang, China

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

Phase 4

Conditions: HIV Infections
COVID-19

Interventions: Biological: Inactivated COVID-19 vaccine

First Posted Date: 2021-10-12

Last Posted Date: 2021-10-22

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 400

Registration Number: NCT05075044

Locations: 🇨🇳
Hubei Center for Disease Control and Prevention, Wuhan, Hubei, China

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD

Phase 4

Conditions: Copd
COVID-19
Chronic Bronchitis

Interventions: Biological: Inactivated COVID-19 vaccine

First Posted Date: 2021-10-12

Last Posted Date: 2021-10-22

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 400

Registration Number: NCT05075057

Locations: 🇨🇳
Hubei Center for Disease Control and Prevention, Wuhan, Hubei, China

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes

Phase 4

Completed

Conditions: COVID-19 Pneumonia

Interventions: Biological: COVAX

First Posted Date: 2021-10-04

Last Posted Date: 2022-01-10

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 1440

Registration Number: NCT05065879

Locations: 🇨🇳
Nan'an Center for Disease Control and Prevention, Quanzhou, Fujian, China
🇨🇳
Yong'an Center for Disease Control and Prevention, Sanming, Fujian, China
🇨🇳
Linli County Center for Disease Control and Prevention, Changde, Hunan, China

and more 2 locations

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes

Phase 4

Conditions: COVID-19 Pneumonia

Interventions: Biological: COVAX

First Posted Date: 2021-10-04

Last Posted Date: 2021-10-25

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 1440

Registration Number: NCT05065892

Locations: 🇨🇳
Songtao Miao Autonomous County Center for Disease Control and Prevention, Tongren, Guizhou, China
🇨🇳
Nan'an Center for Disease Control and Prevention, Quanzhou, Fujian, China
🇨🇳
You County Center for Disease Control and Prevention, Zhuzhou, Hunan, China

Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above

Phase 3

Completed

Conditions: COVID-19 Pneumonia
COVID-19

Interventions: Biological: SARS-CoV-2 Vaccine (Vero Cell), Inactivated

First Posted Date: 2021-06-08

Last Posted Date: 2023-06-18

Lead Sponsor: China National Biotec Group Company Limited

Target Recruit Count: 1800

Registration Number: NCT04917523

Locations: 🇦🇪
Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy